Harvard Bioscience, Inc.
HBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $7 | $6 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $12 | $13 | $15 |
| Inventory | $22 | $22 | $23 | $23 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $44 | $45 | $45 | $45 |
| Property Plant & Equip (Net) | $12 | $12 | $12 | $11 |
| Goodwill | $10 | $10 | $9 | $56 |
| Intangibles | $8 | $9 | $10 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $4 | $4 | $3 |
| Total NC Assets | $34 | $35 | $35 | $82 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $78 | $80 | $80 | $127 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $5 |
| Short-Term Debt | $35 | $36 | $37 | $38 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $3 | $3 | $4 |
| Other Curr. Liab. | $10 | $11 | $10 | $8 |
| Total Curr. Liab. | $54 | $55 | $56 | $55 |
| LT Debt | $7 | $7 | $7 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $1 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $10 | $9 | $9 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $9 | $8 |
| Total Liabilities | $64 | $64 | $65 | $63 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$212 | -$211 | -$208 | -$158 |
| AOCI | -$12 | -$12 | -$14 | -$16 |
| Other Equity | $238 | $238 | $237 | $237 |
| Total Equity | $14 | $16 | $15 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $78 | $80 | $80 | $127 |
| Net Debt | $36 | $36 | $39 | $40 |